SmPC - Aripiprazole 5mg Tablets (PLGB): Change history
View Summary of Product Characteristics (SmPC - Aripiprazole 5mg Tablets (PLGB))
Last updated on this site: 18 Jan 2023
To update section 4.8 of the SmPC and section 4 of the PIL in line with the reference product, Abilify tablets; updated with outcome of procedure EMEA/H/C/000471/IB/0140, MAH: Otsuka Pharmaceutical Netherlands B.V.; NL for Aripiprazole Accord 5/10/15/30 mg tablets.
View Summary of Product Characteristics (SmPC - Aripiprazole 5mg Tablets (PLGB))
Last updated on this site: 18 Jan 2023
To update section 4.8 of the SmPC and section 4 of the PIL in line with the reference product, Abilify tablets; updated with outcome of procedure EMEA/H/C/000471/IB/0140, MAH: Otsuka Pharmaceutical Netherlands B.V.; NL for Aripiprazole Accord 5/10/15/30 mg tablets.
-
Changes: (Updated: 18 Jan 2023)
To update section 4.8 of the SmPC and section 4 of the PIL in line with the reference product, Abilify tablets; updated with outcome of procedure EMEA/H/C/000471/IB/0140, MAH: Otsuka Pharmaceutical Netherlands B.V.; NL for Aripiprazole Accord 5/10/15/30 mg tablets.
-
Changes: (Updated: 23 Sep 2022)
Unlinked from 0142
-
Changes: (Updated: 20 Sep 2022)
Initial upload